Neuroscience Daily for 18 September: Schizophrenia Autoantibodies, Germany Neurotech, Height Avoidance

Neuroscience Daily for 18 September covers 3 neuroscience stories on schizophrenia autoantibodies, germany neurotech, height avoidance. It is a compact audio briefing on studies, mechanisms, and the discussion around them.

Show Notes

Neuroscience Daily for 18 September follows 3 stories from r/neuro and r/neuroscience, moving through schizophrenia autoantibodies, germany neurotech, height avoidance.

Chapters

• 00:00:00 — Intro
• 00:00:13 — Schizophrenia Autoantibodies
• 00:01:27 — Germany Neurotech
• 00:02:23 — Height Avoidance
• 00:03:21 — Closing

1. Schizophrenia Autoantibodies

The first story is a bioRxiv study asking how immune activity may relate to schizophrenia. Researchers used a proteome-scale assay to profile autoantibodies in 352 people with schizophrenia and 971 community controls.

Source link

Reddit discussion

2. Germany Neurotech

The second story is a community-made map of neurotechnology companies in Germany and Austria. The post catalogs 59 organizations working across digital therapeutics, EEG, neuromodulation, neuroimaging, rehabilitation, surgical tools, and assistive technology.

Source link

Reddit discussion

3. Height Avoidance

The third story is a bioRxiv preprint on how mice avoid heights. Researchers built a virtual pole-descent task that let mice repeat height-related choices without quickly habituating to the situation.

Source link

Reddit discussion

That's it for today.

What is Neuroscience Daily: 5-minute briefing?

The most talked-about neuroscience discoveries, studies and breakthroughs, distilled into a five-minute daily briefing. From brain health and cognition to sleep, memory and consciousness, stay on top of the research shaping how we understand the mind.